Fundz

GlycanAge raises $8.7 million in a funding round led by Fifth Quarter Ventures to advance its diagnostic technology and expand glycan testing access.

PRIVATEDec 18, 2025

Amount Raised

$8.7 Million

Round Type

Funding Round

Newcastle Upon TyneBiotechnologyHealth Care

Investors

Vesna Deep Tech VCLightfield EquityBrightCap VenturesLaunchHub VenturesGuinness VenturesSouth Central VenturesImpetus CapitalKadmos CapitalFifth Quarter Ventures

Description

GlycanAge has raised $8.7 million in a targeted funding round to accelerate the clinical development of its glycan testing technology. The round was led by Fifth Quarter Ventures with participation from various investors. This funding aims to transition from wellness biomarker applications to hospital diagnostics. GlycanAge's technology is already being used in preventive and longevity clinics worldwide.

Quick answer

GlycanAge raised $8.7 Million in a Funding Round round, dated December 18, 2025. Investors: Vesna Deep Tech VC, Lightfield Equity, BrightCap Ventures, LaunchHub Ventures, Guinness Ventures, South Central Ventures, Impetus Capital and Kadmos Capital. GlycanAge is based in Newcastle Upon Tyne, England, United Kingdom.

How much did GlycanAge raise?
GlycanAge raised $8.7 Million in a Funding Round round on December 18, 2025.
Who invested in GlycanAge?
Vesna Deep Tech VC, Lightfield Equity, BrightCap Ventures, LaunchHub Ventures, Guinness Ventures, South Central Ventures, Impetus Capital and Kadmos Capital are named as investors in this round.
What does GlycanAge do?
GlycanAge is redefining the way we understand and measure aging.
Where is GlycanAge based and how big is it?
GlycanAge is based in Newcastle Upon Tyne, England, United Kingdom. Fundz records about 42 employees.
Who are the decision-makers at GlycanAge?
Fundz holds 1 contact at GlycanAge. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as GlycanAge that raised within 45 days of this round, from Fundz verified event records.

  • ORamaVR raised $4.5M (Seed) on January 30, 2026.
  • CytoDyn raised $19M on January 30, 2026.
  • Richtech Robotics raised $39M (Post-IPO Equity) on January 29, 2026.
  • Biopeak raised $2.7M (Seed) on January 29, 2026.
  • Tenpoint Therapeutics raised $235M (Series B) on January 29, 2026.
  • PranaX raised $17M (Series A) on January 29, 2026.

Who to call at GlycanAge, and when

A new round usually means GlycanAge is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GlycanAge raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GlycanAge, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GlycanAge. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GlycanAge

Location

Newcastle Upon Tyne, England, United Kingdom

About

GlycanAge is redefining the way we understand and measure aging. Backed by more than 30 years of research and over 300 peer-reviewed publications, the company focuses on glycans—complex molecules that regulate inflammation and immune system function. These biomarkers provide a unique window into biological age, revealing how lifestyle choices, chronic inflammation, and environmental factors shape the aging process.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GlycanAge raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for GlycanAge's next move

See what Strategic adds

GlycanAge raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.